**Patient Discharge Summary**

**Patient Details:**  
- Name: [Patient Name]  
- Age: [Patient Age]  
- Sex: [Patient Sex]  
- Admission Date: November 10, 2023  
- Discharge Date: November 18, 2023  
- Attending Physician: Dr. [Physician's Name]  
- Diagnosis: Influenza  

**Hospital Course:**  
[Patient Name] was admitted to the infectious diseases unit of the hospital on November 10, 2023, with complaints of high fever, cough, severe body aches, and fatigue. The patient reported that the symptoms had started approximately three days prior to admission. Given the prevalence of influenza in the community and the patient's presenting symptoms, influenza was suspected.

Upon admission, the patient underwent a rapid antigen test for influenza, which returned positive for Influenza A. To confirm the diagnosis and to guide antiviral therapy, a nasopharyngeal swab was collected and sent for RT-PCR testing. The RT-PCR test confirmed Influenza A infection. Based on the diagnosis and the patient's severe symptoms, antiviral treatment was initiated.

**Laboratory and Imaging Findings:**  
- Rapid antigen test for influenza: Positive for Influenza A  
- RT-PCR test for influenza: Confirmed Influenza A  
- Pulse oximetry on admission: 94% on room air  
- Chest X-ray: No signs of pneumonia, with findings suggestive of viral infection  

**Treatment:**  
Given the severity of symptoms and the confirmed diagnosis of Influenza A, the patient was started on antiviral therapy. Oseltamivir 75 mg orally twice a day was prescribed, initiated within the first 48 hours of symptom onset. The treatment course was planned for 5 days.

In addition, supportive care including hydration, rest, and antipyretics was provided. Acetaminophen was given for fever and body aches, avoiding aspirin due to the risk of Reye's syndrome.

**Response to Treatment:**  
The patient showed significant improvement within 48 hours of initiating antiviral therapy. Fever resolved by the third day of treatment, and the severity of the cough and body aches decreased notably. By November 17, 2023, the patient was asymptomatic, with only mild residual fatigue.

**Discharge Plan:**  
- [Patient Name] was discharged on November 18, 2023, with instructions to complete the 5-day course of Oseltamivir.
- The patient was advised to continue resting at home and to maintain adequate hydration.
- A follow-up appointment with Dr. [Physician's Name] was scheduled for November 25, 2023, to ensure the complete resolution of symptoms and to address any potential complications.
- The patient was educated on the importance of annual influenza vaccination to prevent future infections.

**Precautions:**  
- The patient was advised to avoid close contact with high-risk individuals until 24 hours after the resolution of fever without the use of antipyretics.
- Hand hygiene and respiratory etiquette were emphasized to prevent the spread of the virus.

**Conclusion:**  
[Patient Name] was successfully treated for Influenza A in the infectious diseases unit with antiviral therapy and supportive care. The patient responded well to the treatment and was discharged in stable condition with instructions for home care and follow-up.

**Attending Physician:**  
Dr. [Physician's Name]  
Infectious Diseases Unit  
[Hospital Name]  
[Discharge Date: November 18, 2023]